Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Allele-specific PCR for determination of IL28B genotype.

Literature DB >> 23052312

Allele-specific PCR for determination of IL28B genotype.

Linda Cook¹, Kurt Diem, Woo Kim, John D Scott, Keith R Jerome.

Abstract

The IL28B genotype is a critical determinant of interferon response in patients infected with hepatitis C virus genotype 1. We describe an allele-specific PCR assay for the IL28B genotype. The assay is simple and robust, uses commonly available real-time PCR instrumentation, and is well suited for clinical laboratories offering IL28B genotyping.

Entities: Gene Species

Mesh：

Substances：

Year: 2012 PMID： 23052312 PMCID： PMC3502971 DOI： 10.1128/JCM.02084-12

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

20 in total

1. Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C.

Authors: Albert Friedrich Stättermayer; Rudolf Stauber; Harald Hofer; Karoline Rutter; Sandra Beinhardt; Thomas Matthias Scherzer; Kerstin Zinober; Christian Datz; Andreas Maieron; Emina Dulic-Lakovic; Harald H Kessler; Petra Steindl-Munda; Michael Strasser; Christoph Krall; Peter Ferenci
Journal: Clin Gastroenterol Hepatol Date: 2010-08-20 Impact factor: 11.382

2. Interleukin-28B genotyping by melt-mismatch amplification mutation assay PCR analysis using single nucleotide polymorphisms rs12979860 and rs8099917, a useful tool for prediction of therapy response in hepatitis C patients.

Authors: Salvador Fonseca-Coronado; Gilberto Vaughan; Mayra Yolanda Cruz-Rivera; Juan Carlos Carpio-Pedroza; Karina Ruiz-Tovar; Juan Alberto Ruiz-Pacheco; Alejandro Escobar-Gutiérrez
Journal: J Clin Microbiol Date: 2011-05-25 Impact factor: 5.948

Review 3. IL28B single nucleotide polymorphisms in the treatment of hepatitis C.

Authors: Christian M Lange; Stefan Zeuzem
Journal: J Hepatol Date: 2011-03-25 Impact factor: 25.083

4. Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b.

Authors: Tomokazu Kawaoka; C Nelson Hayes; Waka Ohishi; Hidenori Ochi; Toshiro Maekawa; Hiromi Abe; Masataka Tsuge; Fukiko Mitsui; Nobuhiko Hiraga; Michio Imamura; Shoichi Takahashi; Michaki Kubo; Tatsuhiko Tsunoda; Yusuke Nakamura; Hiromitsu Kumada; Kazuaki Chayama
Journal: J Hepatol Date: 2010-09-19 Impact factor: 25.083

5. IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

Authors: Thomas J Urban; Alexander J Thompson; Shelton S Bradrick; Jacques Fellay; Detlef Schuppan; Kenneth D Cronin; Linda Hong; Alexander McKenzie; Keyur Patel; Kevin V Shianna; John G McHutchison; David B Goldstein; Nezam Afdhal
Journal: Hepatology Date: 2010-10-07 Impact factor: 17.425

6. Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients.

Authors: Shingo Nakamoto; Tatsuo Kanda; Fumio Imazeki; Shuang Wu; Makoto Arai; Keiichi Fujiwara; Osamu Yokosuka
Journal: Scand J Gastroenterol Date: 2011-07 Impact factor: 2.423

7. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.

Authors: Hans L Tillmann; Alex J Thompson; Keyur Patel; Manfred Wiese; Hannelore Tenckhoff; Hans D Nischalke; Yuliya Lokhnygina; Ulrike Kullig; Uwe Göbel; Emanuela Capka; Johannes Wiegand; Ingolf Schiefke; Wolfgang Güthoff; Kurt Grüngreiff; Ingrid König; Ulrich Spengler; Jeanette McCarthy; Kevin V Shianna; David B Goldstein; John G McHutchison; Jörg Timm; Jacob Nattermann
Journal: Gastroenterology Date: 2010-07-14 Impact factor: 22.682

8. Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays.

Authors: Noah G Hoffman; Linda Cook; Ederlyn E Atienza; Ajit P Limaye; Keith R Jerome
Journal: J Clin Microbiol Date: 2008-06-18 Impact factor: 5.948

9. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.

Authors: Vijayaprakash Suppiah; Max Moldovan; Golo Ahlenstiel; Thomas Berg; Martin Weltman; Maria Lorena Abate; Margaret Bassendine; Ulrich Spengler; Gregory J Dore; Elizabeth Powell; Stephen Riordan; David Sheridan; Antonina Smedile; Vincenzo Fragomeli; Tobias Müller; Melanie Bahlo; Graeme J Stewart; David R Booth; Jacob George
Journal: Nat Genet Date: 2009-09-13 Impact factor: 38.330

10. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors: David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal: Nature Date: 2009-10-08 Impact factor: 49.962

2 in total

1. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.

Authors: Rikke Olesen; Selena Vigano; Thomas A Rasmussen; Ole S Søgaard; Zhengyu Ouyang; Maria Buzon; Arman Bashirova; Mary Carrington; Sarah Palmer; Christel R Brinkmann; Xu G Yu; Lars Østergaard; Martin Tolstrup; Mathias Lichterfeld
Journal: J Virol Date: 2015-07-29 Impact factor: 5.103

2. Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients.

Authors: Loralie J Langman; Lior Nesher; Dimpy P Shah; Jacques M Azzi; Elizabeth J Shpall; Katy Rezvani; John L Black; Roy F Chemaly
Journal: J Mol Diagn Date: 2016-06-29 Impact factor: 5.568

2 in total